| | | Single nucleotide variant (missense variant +1 more) | Nephrolithiasis | |
| | | Single nucleotide variant (missense variant) | not provided +1 more | |
| | | Single nucleotide variant (missense variant) | not provided +3 more | |
| | | Single nucleotide variant (missense variant) | Nephrocalcinosis +1 more | |
| | | Single nucleotide variant (missense variant) | not provided | |
| | | Deletion (frameshift variant) | Cystinuria | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (intron variant) | not provided +1 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (synonymous variant +1 more) | not provided +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Nephrocalcinosis +1 more | |
| | | Single nucleotide variant | Difficulty walking +12 more | |
| | | Translocation | Limb joint contracture +20 more | |
| | | Deletion (frameshift variant) | not provided | |
| | | Single nucleotide variant (splice donor variant) | not provided +1 more | |
| | | Single nucleotide variant (missense variant) | Primary hyperoxaluria +2 more | |
| | | Deletion (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | not provided +1 more | |
| | | Single nucleotide variant (missense variant) | Primary hypomagnesemia | |
| | | Single nucleotide variant (missense variant) | AGXT-related condition +3 more | |
| | | Single nucleotide variant (missense variant) | Primary hyperoxaluria +2 more | |
| | | Deletion (frameshift variant) | not provided +1 more | |
| | | Single nucleotide variant (missense variant) | NHERF1-related condition +2 more | |